Cargando…

Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

Detalles Bibliográficos
Autores principales:	Raninga, Prahlad V., Trapani, Giovanna Di, Vuckovic, Slavica, Bhatia, Maneet, Tonissen, Kathryn F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092342/ https://www.ncbi.nlm.nih.gov/pubmed/33953848 http://dx.doi.org/10.18632/oncotarget.27444

Ejemplares similares

Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
por: Raninga, Prahlad V., et al.
Publicado: (2015)

Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma
por: Raninga, Prahlad V., et al.
Publicado: (2016)

Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer
por: Raninga, Prahlad V., et al.
Publicado: (2014)

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma
por: Sze, Jun Hui, et al.
Publicado: (2019)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
por: Clapper, Erin, et al.
Publicado: (2020)

The thioredoxin system in breast cancer cell invasion and migration
por: Bhatia, Maneet, et al.
Publicado: (2015)

Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis
por: Lu, Yaoying, et al.
Publicado: (2021)

Investigating the Thioredoxin and Glutathione Systems’ Response in Lymphoma Cells after Treatment with [Au(d2pype)2]Cl
por: Wang, Sicong, et al.
Publicado: (2021)

Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation
por: Karlenius, Therese Christina, et al.
Publicado: (2010)

Genomic organisation and alternative splicing of mouse and human thioredoxin reductase 1 genes
por: Osborne, Simone A, et al.
Publicado: (2001)

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019)

Correction: Tuning of Thioredoxin Redox Properties by Intramolecular Hydrogen Bonds
por: Røhr, Åsmund Kjendseth, et al.
Publicado: (2013)

Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma
por: Wang, Sicong, et al.
Publicado: (2023)

Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
por: Yu, Bo, et al.
Publicado: (2020)

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
por: De Beule, Nathan, et al.
Publicado: (2018)

Correction to: Isatuximab: A Review of Its Use in Multiple Myeloma
por: Frampton, James E.
Publicado: (2021)

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
por: McCurdy, Arleigh, et al.
Publicado: (2023)

Correction: Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target
por: Kuntz, Angela N, et al.
Publicado: (2007)

Correction: Mannino et al. Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells. Cancers 2021, 13, 5741
por: Mannino, Federica, et al.
Publicado: (2023)

Application of traditional Chinese medicine as skin depigmentation agents
por: Liu, Tina, et al.
Publicado: (2022)

Correction: Semen Levels of Spermatid-Specific Thioredoxin-3 Correlate with Pregnancy Rates in ART Couples
por: Buckman, Clayton, et al.
Publicado: (2013)

Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma
por: Zheng, Zhihong, et al.
Publicado: (2018)

Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
por: Farooq, Asim V., et al.
Publicado: (2020)

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
por: Chim, C. S., et al.
Publicado: (2019)

Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Xia, Tian, et al.
Publicado: (2021)

Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
por: Girgis, Suzette, et al.
Publicado: (2022)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023)

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
por: Lopez-Muñoz, N., et al.
Publicado: (2023)

Correction: Interaction between M-Like Protein and Macrophage Thioredoxin Facilitates Antiphagocytosis for Streptococcus equi ssp. zooepidemicus
por: Ma, Zhe, et al.
Publicado: (2012)

Correction: Identification of OmpR-Family Response Regulators Interacting with Thioredoxin in the Cyanobacterium Synechocystis sp. PCC 6803
por: Kadowaki, Taro, et al.
Publicado: (2015)

Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
por: Peng, Wei, et al.
Publicado: (2020)

Correction: Ex-Vivo Dynamic 3-D Culture of Human Tissues in the RCCS™ Bioreactor Allows the Study of Multiple Myeloma Biology and Response to Therapy
por: Ferrarini, Marina, et al.
Publicado: (2013)

Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
por: Yellapantula, Venkata, et al.
Publicado: (2020)

Author Correction: Accelerated single cell seeding in relapsed multiple myeloma
por: Landau, Heather J., et al.
Publicado: (2021)

Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
por: Giallongo, Cesarina, et al.
Publicado: (2019)

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
por: Went, Molly, et al.
Publicado: (2019)

Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
por: Aoki, Yuka, et al.
Publicado: (2013)

Correction: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
por: Gkotzamanidou, M., et al.
Publicado: (2020)

Correction Notice: Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Publicado: (2021)

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sb8bkcrqb1ugl72r35lb69ijiv